In a peer-reviewed Perspective (review) article, researchers at the University of Nebraska Medical Center have uncovered concerning evidence that commonly prescribed medications may interfere with crucial brain development processes by disrupting sterol biosynthesis. Their findings, published today in Brain Medicine (Genomic Press, New York), suggest that this previously overlooked mechanism could have significant implications for medication safety during pregnancy and early development.
What we’ve discovered is that many prescription medications, while designed for entirely different purposes, can inadvertently interfere with the brain’s ability to produce and process sterols, including cholesterol. This is particularly concerning because the brain requires precise sterol regulation for proper…